沃兰德药业有限公司成立于1995年,专注于医药原料药生产,现主要产品有盐酸去氧肾上腺素、琥珀酸多西拉敏、依普利酮、乐卡地平等。

Founded in 1995,Shenzhen Oriental Pharma focussed on the production of Active Pharma Ingredients (APIs) ,Now the main product is Phenylephrine Hcl (PE), Doxylamine succinate, Eplerenone and Lercanidipine Hcl.

我们有着14年盐酸去氧肾上腺素的生产经验, 该产品于2004年通过中国GMP认证,09年通过GMP再认证。

14years production experience for Phenylephrine Hcl,granted the GMP for PE in 2004,re-certified in 2009 

2005年向美国FDA提交了DMF文件（ DMF # 18799 ），现销售到美国市场的PE均用于OTC产品。

A DMF has been submitted to FDA in 2005 (DMF # 18799). Rochem International Inc. is our U.S. Regulatory Agent for this DMF. Since the PE we sell to the U.S. market today is for OTC.

根据客户的需要，我们可以提供符合美国、欧洲和中国药典标准的PE产品，同时可提供不同的粒度规格的产品。现可提供的粒度规格有50目、100目、200目和300目

According to the customer’s needs, we can supply the PE conforming to the current standard of USP, EP and CP .At the same time,we can  supply various particle sizes product.Now the particle sizes of  50mesh, 100mesh, 200 mesh and 300mesh are available 

从2000年开始我们出口PE到美国市场,现还出口到欧洲的希腊、比利时、俄罗斯，中东的伊朗和巴基斯坦，及亚洲的香港和韩国等国家和地区。

We export PE to the US market since 2000,now export to the Greece, Belgium and Russia of Euro market, Iran and Pakistan of Middle East market, Hongkong and Korea of Asia market,etc

现盐酸去氧肾上腺素年设计产能为60吨。随着市场需求的增大，我们有计划进行扩建，产能可以翻倍增加。

The design capacity for PE is 60 tons，along with the increase of market demand, we planned extension to double the capacity.

优质的产品和周到的服务赢得了广大客户的认可和赞誉

With high-quality products and attentive service, we have won the majority of customer recognition and praise.